{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:43:38Z","timestamp":1789411418462,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ncl.2025.11.001","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:09:41Z","timestamp":1768306181000},"page":"169-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nonarteritic Anterior Ischemic Optic Neuropathy"],"prefix":"10.1016","volume":"44","author":[{"given":"Osama H.","family":"Ababneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmeh K.","family":"Al-Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva R.","family":"Fashho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad T.","family":"Qatawneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000027399","article-title":"Role of nocturnal arterial hypotension in optic nerve head ischemic disorders","volume":"213","author":"Hayreh","year":"1999","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/eye.2014.144","article-title":"Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy","volume":"29","author":"Miller","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.ncl.2025.11.001_bib3","article-title":"Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.ncl.2025.11.001_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/bjo-2022-322254","article-title":"Vascular supply of the optic nerve head: implications for optic disc ischaemia","volume":"107","author":"Arnold","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ncl.2025.11.001_bib5","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.ophtha.2016.08.017","article-title":"Demographic, systemic, and ocular factors associated with nonarteritic anterior ischemic optic neuropathy","volume":"123","author":"Cestari","year":"2016","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ncl.2025.11.001_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjophthalmol-2017-311140","article-title":"Prevalence and incidence of non-arteritic anterior ischaemic optic neuropathy in South Korea: a nationwide population-based study","volume":"102","author":"Lee","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ncl.2025.11.001_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archopht.1969.00990020792015","article-title":"Ultrastructure of human and monkey Lamina cribrosa and optic nerve head","volume":"82","author":"Anderson","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2025.11.001_bib8","first-page":"93","article-title":"The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis)","volume":"111","author":"Arnold","year":"2013","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"10.1016\/j.ncl.2025.11.001_bib9","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/bjo.2006.093559","article-title":"Retrobulbar haemodynamics in non-arteritic anterior ischaemic optic neuropathy","volume":"90","author":"Kaup","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.ncl.2025.11.001_bib11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jocn.2009.04.002","article-title":"Non-arteritic anterior ischaemic optic neuropathy: a review and update","volume":"16","author":"Kerr","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"5","key":"10.1016\/j.ncl.2025.11.001_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)70902-X","article-title":"Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss","volume":"124","author":"HAYREH","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ncl.2025.11.001_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archopht.1996.01100140566007","article-title":"Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041327-199503000-00002","article-title":"Pain in anterior ischemic optic neuropathy","volume":"15","author":"Swartz","year":"1995","journal-title":"J Neuro Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/vision7040072","article-title":"Non-arteritic anterior ischemic optic neuropathy (NA-AION): a comprehensive overview","volume":"7","author":"Salvetat","year":"2023","journal-title":"Vision"},{"key":"10.1016\/j.ncl.2025.11.001_bib16","article-title":"Color vision in anterior ischemic optic neuropathy","volume":"19","author":"Pollock","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0301-4738.77024","article-title":"Management of ischemic optic neuropathies","volume":"59","author":"Hayreh","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1941874415583117","article-title":"Neuro-ophthalmological emergencies","volume":"5","author":"Lemos","year":"2015","journal-title":"Neurohospitalist"},{"issue":"9","key":"10.1016\/j.ncl.2025.11.001_bib19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ncl.2025.11.001_bib20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-Reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ncl.2025.11.001_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.ncl.2025.11.001_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.ncl.2025.11.001_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/EB.S54131","article-title":"Optic neuritis as an early sign of multiple sclerosis","volume":"8","author":"Kale","year":"2016","journal-title":"Eye Brain"},{"issue":"5","key":"10.1016\/j.ncl.2025.11.001_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies: an updated review","volume":"93","author":"Grzybowski","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ncl.2025.11.001_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ncl.2025.11.001_bib26","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2147\/OPTH.S55076","article-title":"Diabetic papillopathy with macular edema treated with intravitreal ranibizumab","author":"Kim","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ncl.2025.11.001_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jmg.39.3.162","article-title":"Leber hereditary optic neuropathy","volume":"39","author":"Man","year":"2002","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.ncl.2025.11.001_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08820538.2019.1620792","article-title":"Disc configuration as a risk and prognostic factor in NAION: the impact of cup to disc ratio, disc diameter, and crowding index","volume":"34","author":"Gonz\u00e1lez Mart\u00edn-Moro","year":"2019","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1874364101711010017","article-title":"Macular evaluation w\u0131th spectral domain type optic coherence tomography in eyes with acute nonarteritic ischemic optic neuropathy at the presentation visit","volume":"11","author":"Donmez","year":"2017","journal-title":"Open Ophthalmol J"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WNO.0000000000000621","article-title":"MRI of the optic nerves and chiasm in patients with leber hereditary optic neuropathy","volume":"38","author":"Blanc","year":"2018","journal-title":"J Neuro Ophthalmol"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00041327-200306000-00012","article-title":"Pathogenesis of nonarteritic anterior ischemic optic neuropathy","volume":"23","author":"Arnold","year":"2003","journal-title":"J Neuro Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib32","first-page":"776","article-title":"Non arteritic anterior ischemic optic neuropathy; does anticoagulation help?","volume":"28","author":"Aftab","year":"2016","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib33","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1097\/WNO.0000000000001102","article-title":"Optical coherence tomography angiography characteristics and predictors of visual outcomes in patients with acute and chronic nonarteritic anterior ischemic optic neuropathy","volume":"41","author":"Moon","year":"2021","journal-title":"J Neuro Ophthalmol"},{"issue":"11","key":"10.1016\/j.ncl.2025.11.001_bib34","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/archopht.125.11.1570","article-title":"Lessons from the ischemic optic neuropathy decompression trial","volume":"125","author":"Levin","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ncl.2025.11.001_bib36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/00006982-200310000-00015","article-title":"Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy","volume":"23","author":"Soheilian","year":"2003","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ophtha.2006.07.063","article-title":"Vitrectomy and release of presumed epipapillary vitreous traction for treatment of nonarteritic anterior ischemic optic neuropathy associated with partial posterior vitreous detachment","volume":"114","author":"Modarres","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/eye.2012.296","article-title":"Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial","volume":"27","author":"Rootman","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.ncl.2025.11.001_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/OPTH.S29075","article-title":"Insight into 144 patients with ocular vascular events during VEGF antagonist injections","author":"Mansour","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ncl.2025.11.001_bib40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00417-008-0805-8","article-title":"Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy","volume":"246","author":"Hayreh","year":"2008","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ncl.2025.11.001_bib41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ophtha.2018.03.032","article-title":"Steroids versus no steroids in nonarteritic anterior ischemic optic neuropathy","volume":"125","author":"Saxena","year":"2018","journal-title":"Ophthalmology"},{"issue":"46","key":"10.1016\/j.ncl.2025.11.001_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017861","article-title":"Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9394(14)70448-9","article-title":"The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy","volume":"121","author":"Botelho","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00041327-199712000-00007","article-title":"Aspirin reduces the incidence of second eye NAION: a retrospective study","volume":"17","author":"Kupersmith","year":"1997","journal-title":"J Neuro Ophthalmol"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/01658100903497580","article-title":"Aspirin following non-arteritic ischaemic optic neuropathy\u2014A systematic review and meta-analysis","volume":"34","author":"Stiebel-Kalish","year":"2010","journal-title":"Neuroophthalmology"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9394(14)71038-4","article-title":"Aspirin therapy in nonarteritic anterior ischemic optic neuropathy","volume":"123","author":"Beck","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ncl.2025.11.001_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(02)01639-2","article-title":"The fellow eye in naion: report from the ischemic optic neuropathy decompression trial follow-up study","volume":"134","author":"Newman","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ncl.2025.11.001_bib48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/eye.2008.287","article-title":"LDL apheresis in the treatment of non-arteritic ischaemic optic neuropathy: a 6-month follow-up study","volume":"23","author":"Guerriero","year":"2009","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bjophthalmol-2019-314656","article-title":"Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy","volume":"104","author":"Hayreh","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3341\/kjo.2022.0166","article-title":"Neuroprotective strategies for nonarteritic anterior ischemic optic neuropathy: a systematic review","volume":"37","author":"Budihardja","year":"2023","journal-title":"Kor J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ncl.2025.11.001_bib51","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bjo.2010.191627","article-title":"Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy","volume":"95","author":"Modarres","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ncl.2025.11.001_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220435","article-title":"Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: a randomized pilot study","volume":"14","author":"Parisi","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib53","first-page":"167","article-title":"Bilateral non-arteritic ischemic optic neuropathy treated with HBO2 therapy: a case report of angiographic and electrodiagnostic findings","volume":"43","author":"Di Censo","year":"2016","journal-title":"Undersea Hyperb Med"},{"issue":"4","key":"10.1016\/j.ncl.2025.11.001_bib54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0002-9394(14)72114-2","article-title":"Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy","volume":"122","author":"Arnold","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2025.11.001_bib55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.21037\/sci.2017.11.05","article-title":"Stem cell ophthalmology treatment study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)","volume":"23","author":"Weiss","year":"2017","journal-title":"Stem Cell Invest"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13287-023-03500-7","article-title":"Intravitreal allogeneic mesenchymal stem cells: a non-randomized phase II clinical trial for acute non-arteritic optic neuropathy","volume":"14","author":"Pastor","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.ncl.2025.11.001_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0000000000000473","article-title":"Gene therapy in optic nerve disease","volume":"29","author":"DeBusk","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"issue":"5903","key":"10.1016\/j.ncl.2025.11.001_bib58","first-page":"963","article-title":"Promoting axon regeneration in the adult CNS by modulation of the PTEN\/mTOR pathway","volume":"322","author":"Park","year":"2008","journal-title":"Science (1979)"},{"issue":"2","key":"10.1016\/j.ncl.2025.11.001_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ophtha.2007.05.027","article-title":"Nonarteritic anterior ischemic optic neuropathy. Natural history of visual outcome","volume":"115","author":"Hayreh","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ncl.2025.11.001_bib60","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ophtha.2008.03.020","article-title":"Visual fields at Follow-up in the ischemic optic neuropathy decompression trial","volume":"115","author":"Scherer","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2025.11.001_bib61","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.2147\/IJGM.S364051","article-title":"Vision-related quality of life and association between retinal parameters in patients with non-arteritic anterior ischemic optic neuropathy","volume":"15","author":"Su","year":"2022","journal-title":"Int J Gen Med"},{"issue":"1","key":"10.1016\/j.ncl.2025.11.001_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000528627","article-title":"Risk factors for fellow eye involvement in patients with nonarteritic anterior ischemic optic neuropathy","volume":"66","author":"Li","year":"2023","journal-title":"Ophthalmic Res"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861925000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:20:50Z","timestamp":1776802850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861925000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0733861925000854"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2025.11.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonarteritic Anterior Ischemic Optic Neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2025.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}